Thyrocare Technologies Limited - Asset Resilience Ratio

Latest as of September 2025: 22.52%

Thyrocare Technologies Limited (THYROCARE) has an Asset Resilience Ratio of 22.52% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read THYROCARE current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Rs1.53 Billion

≈ $16.56 Million USD Cash + Short-term Investments

Total Assets

Rs6.80 Billion

≈ $73.56 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2025)

This chart shows how Thyrocare Technologies Limited's Asset Resilience Ratio has changed over time. See what is Thyrocare Technologies Limited's book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Thyrocare Technologies Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Thyrocare Technologies Limited worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs315.40 Million	4.64%
Short-term Investments	Rs1.22 Billion	17.88%
Total Liquid Assets	Rs1.53 Billion	22.52%

Asset Resilience Insights

Good Liquidity Position: Thyrocare Technologies Limited maintains a healthy 22.52% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Thyrocare Technologies Limited Industry Peers by Asset Resilience Ratio

Compare Thyrocare Technologies Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Clinica Baviera MC:CBAV	Diagnostics & Research	14.23%
Centro de Imagem Diagnósticos S.A SA:AALR3	Diagnostics & Research	4.77%
Inoviq Ltd AU:IIQ	Diagnostics & Research	56.29%
Predilife PA:ALPRE	Diagnostics & Research	16.23%
Imagion Biosystems Ltd AU:IBX	Diagnostics & Research	150.16%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%

Annual Asset Resilience Ratio for Thyrocare Technologies Limited (2012–2025)

The table below shows the annual Asset Resilience Ratio data for Thyrocare Technologies Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	27.67%	Rs1.92 Billion ≈ $20.73 Million	Rs6.93 Billion ≈ $74.92 Million	+0.24pp
2024-03-31	27.43%	Rs1.77 Billion ≈ $19.10 Million	Rs6.44 Billion ≈ $69.63 Million	+3.60pp
2023-03-31	23.83%	Rs1.51 Billion ≈ $16.31 Million	Rs6.33 Billion ≈ $68.43 Million	+0.98pp
2022-03-31	22.85%	Rs1.39 Billion ≈ $15.02 Million	Rs6.08 Billion ≈ $65.72 Million	+1.29pp
2021-03-31	21.56%	Rs1.18 Billion ≈ $12.73 Million	Rs5.46 Billion ≈ $59.03 Million	+4.50pp
2020-03-31	17.07%	Rs801.00 Million ≈ $8.66 Million	Rs4.69 Billion ≈ $50.76 Million	-0.68pp
2019-03-31	17.75%	Rs842.40 Million ≈ $9.11 Million	Rs4.75 Billion ≈ $51.34 Million	-5.64pp
2018-03-31	23.39%	Rs1.12 Billion ≈ $12.11 Million	Rs4.79 Billion ≈ $51.80 Million	-2.17pp
2017-03-31	25.55%	Rs1.11 Billion ≈ $12.04 Million	Rs4.36 Billion ≈ $47.13 Million	+3.19pp
2016-03-31	22.37%	Rs916.31 Million ≈ $9.91 Million	Rs4.10 Billion ≈ $44.30 Million	-3.21pp
2015-03-31	25.58%	Rs843.01 Million ≈ $9.12 Million	Rs3.30 Billion ≈ $35.64 Million	-15.68pp
2014-03-31	41.26%	Rs1.01 Billion ≈ $10.97 Million	Rs2.46 Billion ≈ $26.57 Million	+10.93pp
2013-03-31	30.33%	Rs596.03 Million ≈ $6.45 Million	Rs1.97 Billion ≈ $21.25 Million	+30.04pp
2012-03-31	0.29%	Rs4.00 Million ≈ $43.26K	Rs1.37 Billion ≈ $14.82 Million	--

pp = percentage points

About Thyrocare Technologies Limited

NSE:THYROCARE India Diagnostics & Research

Market Cap

$837.40 Million

Rs77.43 Billion INR

Market Cap Rank

#10026 Global

#478 in India

Share Price

Rs486.50

Change (1 day)

+3.36%

52-Week Range

Rs349.55 - Rs1591.90

All Time High

Rs1591.90